CXCL10 and neoplasm: With these cells, we set up a transwell migration assay whereby activated CD8+ T cells were seeded in the top chamber, on top of a monolayer of either glyCAF or non-glyCAF and allowed to migrate towards a gradient of CXCL10 and Ccne1+ tumor cells in the bottom chamber (Fig. 5b).